Tech Company Financing Transactions

Ziarco Funding Round

Ziarco closed a $33.1 million Series B funding round on 11/11/2014. Backers included Lundbeckfond Ventures, New Enterprise Associates and Amgen Ventures.

Transaction Overview

Company Name
Ziarco
Announced On
11/11/2014
Transaction Type
Venture Equity
Amount
$33,100,000
Round
Series B
Investors

Lundbeckfond Ventures (Lead Investor) (Johan Kordel)

New Enterprise Associates (Lead Investor) (Ed Mathers)

Amgen Ventures

Proceeds Purpose
Ziarco plans to use the proceeds from the Series B financing to generate clinical Proof-of-Concept data in patients for its lead compounds -- ZPL-389, an oral histamine H4 receptor antagonist, and ZPL-521, a topical cytosolic phospholipase A2 (cPLA2) inhibitor, in atopic dermatitis and psoriasis, respectively.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
12-17 Upper Bridge St. 205 - 206
Canterbury Kent, CT1 2NF
UK
Phone
(650) 833-5000
Website
www.ziarcopharma.com
Email Address
[email protected]
Overview
Ziarco is an independent, clinical stage biotechnology company progressing novel & differentiated therapies for inflammatory and allergic diseases, using both oral and topical routes of delivery.
Profile
Ziarco LinkedIn Company Profile
Social Media
Ziarco Company Twitter Account
Company News
Ziarco News
Facebook
Ziarco on Facebook
YouTube
Ziarco on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Mike Yeadon
  Mike Yeadon LinkedIn Profile  Mike Yeadon Twitter Account  Mike Yeadon News  Mike Yeadon on Facebook
Chief Scientific Officer
Wai Liu
  Wai Liu LinkedIn Profile  Wai Liu Twitter Account  Wai Liu News  Wai Liu on Facebook
VP - Bus. Development
Lynn Purkins
  Lynn Purkins LinkedIn Profile  Lynn Purkins Twitter Account  Lynn Purkins News  Lynn Purkins on Facebook

 

 

Browse more venture capital transactions:

Prev: 11/11/2014: FourKites venture capital transaction
Next: 11/11/2014: Farmers Edge venture capital transaction

 

Share this article

 

About Our Venture Capital Transactions Database

We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.